Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov;5(4):296-311.
doi: 10.2174/157340309789317823.

Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review

Christos Kasapis  1 , Hitinder S Gurm
Affiliations

Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review

Christos Kasapis et al. Curr Cardiol Rev. 2009 Nov.

Abstract

Peripheral arterial disease (PAD) is a common manifestation of atherosclerosis affecting 5 million adults in the United States, with an age-adjusted prevalence of 4% to 15% and increasing up to 30% with age and the presence of cardiovascular risk factors. In this article we focus on lower extremity PAD and specifically on the superficial femoral and proximal popliteal artery (SFPA), which are the most common anatomic locations of lower extremity atherosclerosis. We summarize current evidence and perform a systematic review on the diagnostic evaluation as well as the medical, endovascular and surgical management of SFPA disease.

Keywords: Peripheral arterial disease; diagnosis; management.; popliteal artery; superficial femoral artery.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Weighted mean prevalence of intermittent claudication (symptomatic PAD) in large population-based studies. Reproduced with permission from [7].
Fig. (2)
Fig. (2)
Approximate range of odds ratios for risk factors for symptomatic peripheral arterial disease. Reproduced with permission from [7].
Fig. (3)
Fig. (3)
Algorithm for diagnosis of peripheral arterial disease. TBI – toe brachial index; VWF – velocity wave form; PVR – pulse volume recording. Reproduced with permission from Hiatt WR. N Engl J Med 2001; 344: 1608-21.
Fig. (4)
Fig. (4)
Overall treatment strategy for peripheral arterial disease. BP – blood pressure; HbA1c – hemoglobin A1c; LDL – low density lipoprotein; MRA – magnetic resonance angiography; CTA – computed tomographic angiography. Reproduced with permission from Hiatt WR. N Engl J Med 2001; 344: 1608-21.
Fig. (5)
Fig. (5)
Algorithm for treatment of the patient with critical limb ischemia. Contraindications are: patients not fit for revascularization; revascularization not technically possible; benefit cannot be expected (i.e. widespread ulceration-gangrene). CLI – critical limb ischemia; MRA – magnetic resonance angiography; CTA – computed tomographic angiography. Reproduced with permission from [7].
Fig. (6)
Fig. (6)
TASC classification of femoral popliteal lesions. CFA – common femoral artery; SFA – superficial femoral artery. Reproduced with permission from [7].
See this image and copyright information in PMC

References

    1. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113:e463–654. - PubMed
    1. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004;110:738–43. - PubMed
    1. Pasternak RC, Criqui MH, Benjamin EJ, et al. Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology. Circulation. 2004;109:2605–12. - PubMed
    1. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317–24. - PubMed
    1. Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1996;25:1172–81. - PubMed